United States · FDA National Drug Code directory
Depo-Medrol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0009-3073_742fcec7-8db3-4cc6-b276-42587a993810
- Product NDC
- 0009-3073
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- methylprednisolone acetate
- Labeler
- Pharmacia & Upjohn Company LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 19590528
- Source listing expiry
- 20271231
Source-listed ingredients
- METHYLPREDNISOLONE ACETATE — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-3073-01) / 1 mL in 1 VIAL, SINGLE-DOSE · 0009-3073-01
- 25 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-3073-03) / 1 mL in 1 VIAL, SINGLE-DOSE · 0009-3073-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →